CVRdatabase
Menu

Bgi Europe A/S

Public limited companyCVR 32931340HerlevActive

Bgi Europe A/S is a public limited company, based in Herlev, active in research and experimental development on natural sciences and engineering, founded in 2010. Equity was negative at the end of 2025 (−DKK 2m). The company made a loss in both 2024 and 2025, most recently DKK 32.2m.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 5m−506.8% vs. 2024
Net profit−DKK 32.2m−105.2% vs. 2024
Equity−DKK 2m−106.4% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 507% (2024 → 2025), to −DKK 5m.
  • The loss grew: from DKK 15.7m to DKK 32.2m (2024 → 2025).
  • Equity turned negative: −DKK 2m (2024 → 2025).

Employees

  • 18 fewer employees than a year earlier: 4 (08/2026) against 22 (08/2025).

Management and owners, last 24 months

  • New in management: Jun Cheng (board member, 10/09/2025) and Jun Cheng (director, 10/09/2025).
  • Stepped down: Ruiqi Xu (board member, 10/09/2025) and Ruiqi Xu (director, 10/09/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 80m−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Bgi Europe A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit18,745−90,40453,34635,4441,236−5,028−506.8%
Operating profit (EBIT)4,841−104,89237,27119,800−19,724−27,008−36.9%
Profit before tax2,088−104,56532,76419,315−20,344−27,694−36.1%
Net profit2,775−79,85825,02614,457−15,695−32,211−105.2%
Total assets219,956427,143220,578192,298182,224130,088−28.6%
Equity86,3306,47331,49945,95630,260−1,951−106.4%
Liabilities133,351420,670189,079146,342151,963132,039−13.1%
Cash and cash equivalents169,465307,06478,97810,49711,6944,373−62.6%
Average number of employees161922212220−9.1%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 100m−DKK 80m−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 2m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Bgi Europe A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202506/08/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202430/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202329/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202204/08/2023The companyPDFXBRL
202101/01/2021 – 31/12/202103/08/2022The companyPDFXBRL
202001/01/2020 – 31/12/202001/09/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202509/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 5mNo. 372 of 421
Better than 12% of the companies in the industry
Equity−DKK 2mNo. 359 of 431
Better than 17% of the companies in the industry
Number of employees4No. 91 of 431
Better than 79% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,527of 69,742
Better than 0%
No. 68,206of 69,964
Better than 3%
Same industry and fewer than 20 employees329 companies in the comparison
No. 292of 323
Better than 10%
No. 269of 329
Better than 18%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,712of 24,791
Better than 0%
No. 24,438of 24,909
Better than 2%
All companies of type A/S18,025 companies in the comparison
No. 17,639of 17,786
Better than 1%
No. 17,505of 18,024
Better than 3%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Bgi Europe A/S−DKK 5m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Bgi Europe A/S−DKK 32.2m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Bgi Europe A/S−DKK 2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Bgi Europe A/S4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • BGI Genomics Co., Ltd.100%
Bgi Europe A/S

Management

5 active registrations

Executive management

Executive management at Bgi Europe A/S
NameRoleAppointed
Jun ChengDirector10/09/2025

Board of directors

Board of directors at Bgi Europe A/S
NameRoleAppointed
Ning LiChair of the board31/10/2022
CAO SujieBoard member31/10/2022
Hao ZengBoard member31/10/2022
Jun ChengBoard member10/09/2025
Founders
Philip Martin Graff
Former management (12)
Former management at Bgi Europe A/S
NameRoleAppointedResigned
Songgang LiBoard member17/05/201007/05/2012
Tong ZhangChair of the board17/05/201007/05/2012
Man Fung MakBoard member17/05/201007/05/2012
Man Fung MakCEO17/05/201007/06/2011
Ning LiDirector07/06/201131/10/2022
Jian WangChair of the board07/05/201231/10/2022
Shengquan HuangBoard member07/05/201206/12/2017
Yingrui LiBoard member07/05/201230/06/2016
Ning LiBoard member30/06/201630/10/2022
Yu Tak Kin DuncanBoard member06/12/201731/10/2022
Ruiqi XuBoard member31/10/202210/09/2025
Ruiqi XuDirector31/10/202210/09/2025

Signing rule: Selskabet tegnes af 2 medlemmer af bestyrelsen i forening, af direktionen alene eller af bestyrelsesformanden alene.

Address and production units

1 active production units

Symfonivej 34
2730 Herlev

Herlev Municipality · Postcode 2730

Production units
Production unitAddressEmployeesP number
BGI EUROPE A/SSymfonivej 34, 2730 Herlev41016042575

Purpose

Selskabets formål er at drive virksomhed med forskning, teknologisk udvikling, produktudvikling, produktion og markedsføring indenfor medicinalsektoren, herunder indenfor biovidenskab, laboratorieservices, herunder gentestning, bioteknologi, bio-information og sundhedspleje samt hertil relateret virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

46 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20256 changesmanagement 4 · accounts 1 · industry 1
  • JUN CHENG appointed director
  • JUN CHENG appointed board member
  • Ruiqi Xu stepped down as director
  • Ruiqi Xu stepped down as board member
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20232 changesaccounts 1 · address 1
  • Annual report for 2022 published
  • Moved to Symfonivej 34, 2730 Herlev
202210 changesmanagement 9 · accounts 1
  • CAO Sujie appointed board member
  • Ning Li appointed chair of the board
  • Ruiqi Xu appointed director
  • Ruiqi Xu appointed board member
  • Hao Zeng appointed board member
  • YU TAK KIN DUNCAN stepped down as board member
  • Jian Wang stepped down as chair of the board
  • Ning Li stepped down as director
  • Ning Li stepped down as board member
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20172 changesmanagement 2
  • YU TAK KIN DUNCAN appointed board member
  • Shengquan Huang stepped down as board member
20162 changesmanagement 2
  • Ning Li appointed board member
  • Yingrui Li stepped down as board member
20153 changesownership 3
  • BGI Diagnosis Co., Ltd. registered as owner (100%)
  • BGI Diagnosis Co., Ltd. is no longer registered as owner
  • BGI Genomics Co., Ltd. registered as owner (100%)
20131 changecapital 1
  • Share capital changed from 5,000,000 DKK to 6,000,000 DKK
20126 changesmanagement 6
  • Yingrui Li appointed board member
  • Shengquan Huang appointed board member
  • Jian Wang appointed chair of the board
  • Tong Zhang stepped down as chair of the board
  • Man Fung Mak stepped down as board member
  • Songgang Li stepped down as board member
20113 changesaddress 1 · management 2
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Ning Li appointed director
  • Man Fung Mak stepped down as ceo
20108 changesaddress 1 · industry 1 · capital 1 · founded 1 · management 4
  • Moved to Bülowsvej 15, 1870 Frederiksberg C
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
  • Share capital changed from 500,000 DKK to 5,000,000 DKK
  • Registered as BGI EUROPE A/S
  • Tong Zhang appointed chair of the board
  • Man Fung Mak appointed ceo
  • Man Fung Mak appointed board member
  • Songgang Li appointed board member

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction